✦ LIBER ✦

Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides

✍ Scribed by Richard D. Moore; Craig R. Smith; Paul S. Lietman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of End-Stage Renal Disease Among Li

✍ R. Ruebner; D. Goldberg; P. L. Abt; R. Bahirwani; M. Levine; D. Sawinski; R. D. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 609 KB

Risk of Renal Allograft Failure Due to R

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Non-alcoholic fatty liver disease and in

✍ Giovanni Targher; Guido Arcaro 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Incidence and risk factors of renal dysf

✍ S.G. Kim; H.J. Kim; J.-P. Lee; S.G. Lee; Y.S. Kim; C. Ahn; J.S. Han; S. Kim; J.S 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Mycophenolate mofetil (MMF) monotherapy

✍ Maria Luisa Raimondo; Lucy Dagher; George Papatheodoridis; Fulya Gunsar; Valerio 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Independent risk factors and natural his

✍ Attaphol Pawarode; Derek M. Fine; Paul J. Thuluvath 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB